Expert Opinion on Pharmacotherapy
Volume 22, 2021 - Issue 8
Open access
5,994
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluation
Evaluating rimegepant for the treatment of migraine
Tessa de VriesErasmus MC, Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Rotterdam, NetherlandsView further author information
, Linda Al-HassanyErasmus MC, Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Rotterdam, NetherlandsView further author information
& Antoinette MaassenVanDenBrinkErasmus MC, Department of Internal Medicine, Division of Pharmacology and Vascular Medicine, Rotterdam, NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0001-7176-126XView further author information
https://orcid.org/0000-0001-7176-126XView further author information
Pages 973-979
|
Received 16 Dec 2020, Accepted 23 Feb 2021, Published online: 10 Mar 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.